Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N2 non-small cell lung cancer

British Journal of Cancer

Volumn 86, Issue 4, 2002, Pages 530-533

  Date, H ^a   Kiura, K ^a   Ueoka, H ^a   Tabata, M ^a   Aoe, M ^a   Andou, A ^a   Shibayama, T ^a   Shimizu, N ^a  

^a OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Induction chemotherapy; Irinotecan; Non small cell lung cancer

Indexed keywords

CISPLATIN; GRANISETRON; GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN; ONDANSETRON;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MALE; MEDIASTINOSCOPY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; THORACOTOMY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; RADIOTHERAPY; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037065961     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600117     Document Type: Article

References (13)

1. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage IIIA (N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805
2. Postoperative complications after combined neoadjuvant treatment of lung cancer
3. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin
4. Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer
5. Toxicity and response criteria of the Eastern Cooperative Oncology Group
6. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with respectable cancer of the lung
7. Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer
8. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: A 7-year assessment of a randomized controlled trial
9. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in respectable stage IIIA non-small-cell lung cancer
10. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial
11. Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer
12. Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: A phase I study
13. Dose-finding study of irinotecan and cisplatin plus concurrent radiotherapy for unresectable stage III non-small-cell lung cancer